+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergan Plc (AGN) - Product Pipeline Analysis, 2018 Update

  • PDF Icon

    Company Profile

  • 66 Pages
  • May 2018
  • GlobalData
  • Allergan plc
  • ID: 4539792
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women’s health, urology and anti-infective therapeutic categories. The company sells its products to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations in several countries across the Americas, Europe, Asia-Pacific, the Middle East and Africa. Allergan is headquartered in Dublin, Ireland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

  • The report analyzes all pipeline products in development for the company Allergan Plc

  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

  • The report provides detailed description of products in development, technical specification and functions

  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

  • To formulate effective Research & Development strategies

  • Develop market-entry and market expansion strategies

  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Allergan Plc Company Overview

  • Allergan Plc Company Snapshot

  • Allergan Plc Pipeline Products and Ongoing Clinical Trials Overview

  • Allergan Plc - Pipeline Analysis Overview

  • Business Description

  • Allergan Plc - Key Facts

  • Allergan Plc - Major Products and Services

  • Allergan Plc Pipeline Products by Development Stage

  • Allergan Plc Ongoing Clinical Trials by Trial Status

  • Allergan Plc Pipeline Products Overview

  • BotuGel

  • BotuGel Product Overview

  • BotuGel Clinical Trial

  • CoolSculpting - Pseudogynocomastia

  • CoolSculpting - Pseudogynocomastia Product Overview

  • CoolSculpting Mini V2

  • CoolSculpting Mini V2 Product Overview

  • Diafert

  • Diafert Product Overview

  • earFold

  • earFold Product Overview

  • earFold Clinical Trial

  • Eplica Silk

  • Eplica Silk Product Overview

  • HA Threads

  • HA Threads Product Overview

  • Helios Insert

  • Helios Insert Product Overview

  • JUVEDERM Volbella

  • JUVEDERM Volbella Product Overview

  • Juvederm Volift - Nasolabial Folds

  • Juvederm Volift - Nasolabial Folds Product Overview

  • LILETTA - 5 Years

  • LILETTA - 5 Years Product Overview

  • LiRIS

  • LiRIS Product Overview

  • MicroCell - Breast Augmentation

  • MicroCell - Breast Augmentation Product Overview

  • Nanotechnology-Based Transdermal Delivery System

  • Nanotechnology-Based Transdermal Delivery System Product Overview

  • Norethindrone Transdermal Delivery System

  • Norethindrone Transdermal Delivery System Product Overview

  • NOVADUR Intravitreal Implant

  • NOVADUR Intravitreal Implant Product Overview

  • OD-01

  • OD-01 Product Overview

  • Phoenix - Breast Augmentation

  • Phoenix - Breast Augmentation Product Overview

  • SeriGel

  • SeriGel Product Overview

  • Thigh Applicator

  • Thigh Applicator Product Overview

  • Vaginal Ring Contraceptive

  • Vaginal Ring Contraceptive Product Overview

  • VYC-25L Hyaluronic Acid Injectable Gel

  • VYC-25L Hyaluronic Acid Injectable Gel Product Overview

  • Zeltiq Applicator - Acne

  • Zeltiq Applicator - Acne Product Overview

  • Zeltiq Applicator - Cellulite

  • Zeltiq Applicator - Cellulite Product Overview

  • Allergan Plc - Key Competitors

  • Allergan Plc - Key Employees

  • Allergan Plc - Key Employee Biographies

  • Allergan Plc - Locations And Subsidiaries

  • Head Office

  • Other Locations & Subsidiaries

  • Recent Developments

  • Allergan Plc, Recent Developments

  • May 07, 2018: Medicines360, WCG, and Population Services International Announce Launch of AVIBELA Hormonal Intrauterine System in Madagascar

  • May 03, 2018: John Davidson Elected to Allergan Board of Directors

  • Apr 30, 2018: Allergan Reports 3% Increase in First Quarter 2018 GAAP Net Revenues to $3.7 Billion

  • Apr 26, 2018: Allergan to Present New Data at the American College of Obstetrics and Gynecology 67th Annual Clinical and Scientific Meeting 2018

  • Apr 13, 2018: Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device During 2018 ASCRS-ASOA Annual Meeting

  • Mar 06, 2018: CoolSculpting Takes to the Ice with Iconic Figure Skater Johnny Weir to Debunk Fat Loss Myths

  • Feb 22, 2018: Access Vascular Receives FDA Clearance for its HydroPICC Catheter

  • Feb 22, 2018: FDA Acceptance of Medicines360's Filing for supplemental New Drug Application for LILETTA (levonorgestrel-releasing intrauterine system) 52 mg

  • Feb 05, 2018: Allergan Appoints Matthew M. Walsh As Executive Vice President and Chief Financial Officer

  • Feb 01, 2018: Japanese Pharmaceutical Company Agrees to 20 Year Settlement Agreement after Attempting to Block Generics

  • Appendix

  • Methodology

  • About

  • Contact

  • Disclaimer


List of Tables
  • Allergan Plc Pipeline Products and Ongoing Clinical Trials Overview

  • Allergan Plc Pipeline Products by Equipment Type

  • Allergan Plc Pipeline Products by Indication

  • Allergan Plc Ongoing Clinical Trials by Trial Status

  • Allergan Plc, Key Facts

  • Allergan Plc, Major Products and Services

  • Allergan Plc Number of Pipeline Products by Development Stage

  • Allergan Plc Pipeline Products Summary by Development Stage

  • Allergan Plc Ongoing Clinical Trials by Trial Status

  • Allergan Plc Ongoing Clinical Trials Summary

  • BotuGel - Product Status

  • BotuGel - Product Description

  • BotuGel - Phase II Study of OnabotulinumtoxinA SR Overactive Bladder

  • CoolSculpting - Pseudogynocomastia - Product Status

  • CoolSculpting - Pseudogynocomastia - Product Description

  • CoolSculpting Mini V2 - Product Status

  • CoolSculpting Mini V2 - Product Description

  • Diafert - Product Status

  • Diafert - Product Description

  • earFold - Product Status

  • earFold - Product Description

  • earFold - Long Term Prospective Uncontrolled Study of Earfold or the Treatment of Prominent Ears: FOLD

  • Eplica Silk - Product Status

  • Eplica Silk - Product Description

  • HA Threads - Product Status

  • HA Threads - Product Description

  • Helios Insert - Product Status

  • Helios Insert - Product Description

  • JUVEDERM Volbella - Product Status

  • JUVEDERM Volbella - Product Description

  • Juvederm Volift - Nasolabial Folds - Product Status

  • Juvederm Volift - Nasolabial Folds - Product Description

  • LILETTA - 5 Years - Product Status

  • LILETTA - 5 Years - Product Description

  • LiRIS - Product Status

  • LiRIS - Product Description

  • MicroCell - Breast Augmentation - Product Status

  • MicroCell - Breast Augmentation - Product Description

  • Nanotechnology-Based Transdermal Delivery System - Product Status

  • Nanotechnology-Based Transdermal Delivery System - Product Description

  • Norethindrone Transdermal Delivery System - Product Status

  • Norethindrone Transdermal Delivery System - Product Description

  • NOVADUR Intravitreal Implant - Product Status

  • NOVADUR Intravitreal Implant - Product Description

  • OD-01 - Product Status

  • OD-01 - Product Description

  • Phoenix - Breast Augmentation - Product Status

  • Phoenix - Breast Augmentation - Product Description

  • SeriGel - Product Status

  • SeriGel - Product Description

  • Thigh Applicator - Product Status

  • Thigh Applicator - Product Description

  • Vaginal Ring Contraceptive - Product Status

  • Vaginal Ring Contraceptive - Product Description

  • VYC-25L Hyaluronic Acid Injectable Gel - Product Status

  • VYC-25L Hyaluronic Acid Injectable Gel - Product Description

  • Zeltiq Applicator - Acne - Product Status

  • Zeltiq Applicator - Acne - Product Description

  • Zeltiq Applicator - Cellulite - Product Status

  • Zeltiq Applicator - Cellulite - Product Description

  • Allergan Plc, Key Employees

  • Allergan Plc, Key Employee Biographies

  • Allergan Plc, Other Locations

  • Allergan Plc, Subsidiaries

  • Glossary


List of Figures
  • Allergan Plc Pipeline Products by Equipment Type

  • Allergan Plc Pipeline Products by Development Stage

  • Allergan Plc Ongoing Clinical Trials by Trial Status

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Gilead Sciences Inc
  • Eli Lilly and Co
  • Bristol-Myers Squibb Co
  • AstraZeneca Plc
  • Amgen Inc
  • AbbVie Inc

Related Topics

Copyright © 2002-2023 Research and Markets. All Rights Reserved.